Shreedevi Kumar, PhD, currently serves as Scientist II at Beam Therapeutics, having progressed from Scientist I since March 2022. Prior to this, Shreedevi was a Post-Doctoral Researcher and Biomedical Engineering Graduate Student at the University of Florida from January 2016 to February 2022, where Shreedevi earned a PhD and Master of Science in Biomedical Engineering. Shreedevi's experience also includes consulting at Deloitte from February 2013 to December 2015, where Shreedevi developed Global Launch Plans for orphan drugs, analyzed processes for a medical devices company, and executed program management strategies for a leading health plan. Previous internships at Millennium Pharmaceuticals and Eastman Kodak contributed to research skills in drug formulations and experimental design. Academic qualifications include a Bachelor of Science in Chemical and Biomolecular Engineering and a Master of Engineering from Cornell University, alongside A-Levels in science subjects from Raffles Institution.
This person is not in the org chart
This person is not in any teams
This person is not in any offices